EAPM - צייט צו פאַרשרייַבן פֿאַר שליסל פערזענליכען מעדיצין קאָנפֿערענץ אויף 12 אקטאבער - פאַרשרייַבן איצט!

Registration is still open for the European Alliance for Personalised Medicine (EAPM) conference entitled 'ענשור אַקסעס צו יננאָוואַטיאָן און דאַטן-רייַך בייאַמאַרקער פּלאַץ צו פאַרגיכערן בעסער קוואַליטעט פון זאָרגן פֿאַר סיטיזענס אין אַ COVID 19 און Post-COVID 19 וועלט ', taking place during the Germany EU Presidency conference which will be a ‘virtual’ event, held online, on 12 October, שרייבט עאַפּם אויספֿיר דירעקטאָר דעניס האָרגאַן. 

ביטע געפֿינען די לינק דאָ צו רעגיסטרירן און די אַגענדאַ איז דאָ.

The Alliance has helped to shape awareness among stakeholders and policymakers over recent years about the needs of modern-day patients, and about the potential of personalised medicine to change healthcare for the better. 

Now, in a world where the landscape has been changed not just by massive advances in science and technology but by the COVID 19 pandemic and the consequent shift in perceptions of the place in health in society, EAPM focused in this latest conference on how more of that “future promise” can be integrated into current clinical practice and health system strategy.

There is potential future promise in the European policy context, with the legislative and policy initiatives currently on the EU agenda. 

The Beating Cancer Plan and the Cancer Mission, the European Health Data Space, the expanded health programme, the review of research incentives and – most recently – the declaration of Commission President Ursula von der Leyen in favour of European Health Union. But for all these potential positives to be realized, it will be necessary to establish a co-created framework involving all stakeholders, and for clear messages to be transmitted from clinical, research and patient communities to policymakers in government, among payers, and in health technology assessment bodies.

To perfectly match the less-than-perfect times we find ourselves in through social distancing, the conference will be socially connected virtually.

אַדווערטייזמאַנט

ביטע געפֿינען די לינק דאָ צו רעגיסטרירן און די אַגענדאַ איז דאָ. 

אַזוי, וואָס זענען צווישן די טעמעס אויף די טיש?

The current COVID-19 crisis has thrown many European, and indeed global, health-care issues into sharp relief.

דאָס האָט אויך אויפגעוועקט וויכטיקע פראגעס, ניט דאַווקע נייַע, אָבער וואָס האָבן זיך מער געשטעלט אין פאָקוס בעשאַס די פּאַנדעמיק.

איין אַזאַ קשיא איז צי די אי.יו. זאָל האָבן אַ גרעסערע ראָלע אין ציבור געזונט - און דער הויפּט אין די טנייַ פון געזונט טעכנאָלאָגיע. This, of course, would impinge upon the closely guarded member state competence in health care so, if this were to happen, how would that be?

Sessions during the presidency conference will address topics such as:

• Opening Session: The Pharmaceutical Strategy of the EU: Developing a Framework to ensure capacity and equitability across the EU
• Session I: Multi-stakeholder approach – Rational Allocation of Resources to support innovation and healthcare system efficiencies – Who to test, when to test and how to test?
• Session II: Cancer: Case Study for EU Coordinated Action on Prostate, Lung, Breast and Cervical Cancer
  
• Session III: Biomarker testing: Piercing the fog of Alzheimer's and related dementia
  
• Session IV: Propelling Healthcare with Advanced Therapy Medicinal Products (ATMPs)
  
•  Closing Session: Realising the potential of Data & Early Diagnosis through biomarker testing & Molecular Diagnostics

ביטע געפֿינען די לינק דאָ צו רעגיסטרירן און די אַגענדאַ איז דאָ. The above are just an example of the huge topics among many up for discussion on the day. So be sure to join us on 12 October.

Therefore, if you are a stakeholder in personalised medicine in particular, or the advancement of healthcare in general, this is the ideal forum for sharing your views and expertise while absorbing that of others.

 We hope to see you in virtually on 12 October!

שער דעם אַרטיקל: